Core Viewpoint - The electromagnetic compatibility (EMC) testing industry in China is experiencing steady growth driven by regulatory improvements, expanding market demand across various sectors, and increasing compliance requirements from both domestic and international markets [1][4][5]. Market Overview - The regulatory framework for EMC testing in China has expanded from traditional consumer electronics to include diverse sectors such as automotive, new energy, medical, rail transportation, and aerospace [1][4]. - The market size of the EMC testing industry in China is projected to reach 6.928 billion yuan by 2025, with a year-on-year growth of 11.7%. EMC testing services account for approximately 76.13% of the market, while EMC testing equipment represents about 23.87% [1][8]. Policy Environment - Recent policies emphasize the importance of product quality and safety, mandating EMC testing for various industries, including automotive, consumer electronics, and aerospace, thereby creating a favorable environment for the EMC testing industry [4][5]. Industry Chain - The upstream of the EMC testing industry includes suppliers of electromagnetic materials and testing equipment, while the downstream encompasses demand markets across multiple sectors such as automotive, consumer electronics, and medical devices [6][7]. Demand Structure - The automotive sector is the largest demand market for EMC testing in China, expected to account for nearly 30% of the market by 2025. The rapid growth of the automotive market, particularly in new energy vehicles, provides significant growth opportunities for the EMC testing industry [7][8]. Competitive Landscape - The EMC testing market in China is characterized by a competitive landscape with a mix of state-owned, foreign, and domestic private testing institutions. The market concentration remains low, indicating intense competition [10]. - Key players in the industry include companies like 广电计量 (Guangdian Measurement), 西安西测 (Xi'an Xice), and others, which are leveraging their technical capabilities and service advantages to capture market share [10][11]. Development Trends - The EMC testing industry is expected to see a continuous improvement in standards and compliance requirements driven by government policies, leading to a more regulated and high-quality market [12]. - Technological advancements will focus on smart and high-end solutions, with AI and automation playing a significant role in enhancing testing efficiency and accuracy [13]. - The service model is shifting towards integrated solutions that encompass testing, rectification, certification, and consulting, aiming to meet the comprehensive needs of enterprises throughout their product lifecycle [14].

Core Insights - The report emphasizes the strong growth potential in the testing services industry, particularly driven by emerging sectors such as commercial aerospace and new technologies [4][6] - The testing services sector is closely linked to macroeconomic growth, with a projected global market size of approximately 2.3 trillion RMB by 2024, reflecting a CAGR of about 6% from 2021 to 2024 [4][24] - In China, the testing services market is expected to reach around 487.6 billion RMB by 2024, with a CAGR of approximately 10.5% from 2015 to 2024, indicating a robust growth trajectory [5][24] Industry Overview - The testing, inspection, and certification (TIC) industry serves various sectors including consumer goods, industrial products, and pharmaceuticals, covering all stages from R&D to production and distribution [16][24] - The industry is characterized by a large market space and stable growth, with demand closely tied to macroeconomic trends and government regulations [20][24] - Emerging technologies such as AI, electric vehicles, and commercial aerospace are expected to create new testing demands, raising the entry barriers for new players [6][20] Company Performance - The report analyzes 19 listed companies in the testing services sector, highlighting their revenue and profit performance, with notable companies including Huace Testing, Guangdian Measurement, and Su Testing [2][11] - In the first three quarters of 2025, the testing services sector in China reported a revenue of 30.4 billion RMB, a decline of 7% year-on-year, but a growth of 3% when excluding companies heavily involved in medical testing [5][57] - Leading companies such as Huace Testing, Guangdian Measurement, and Su Testing demonstrated superior performance, with revenue growth rates of 7%, 12%, and 9% respectively, significantly outpacing the industry average [5][62] Market Dynamics - The testing services market is experiencing a structural shift, with a trend towards consolidation as larger firms gain market share and smaller firms face challenges [44][50] - The report notes that the majority of testing institutions in China are small and micro-sized, which limits their ability to withstand economic pressures [50][51] - Government policies are increasingly supporting the marketization and consolidation of testing institutions, aiming to enhance the overall quality and efficiency of the industry [51][53] Financial Metrics - The report indicates that the average gross margin for the testing services sector has improved, reaching 26.2% in the first three quarters of 2025, reflecting a recovery in profitability [63] - The accounts receivable turnover days have increased from 90 days in 2019 to 176 days in 2025, indicating a slowdown in cash flow and potential credit risks within the industry [67][68] - The report highlights that the proportion of accounts receivable in relation to revenue has risen to 50%, suggesting increasing challenges in managing receivables [71]

Core Viewpoint - The company, Poni Testing (300887), aims to focus on high-potential sectors by 2026, benefiting from policy-driven growth in testing demand, which is expected to improve its financial performance [1]. Business Progress - The company plans to deepen its engagement with major clients in 2026, emphasizing sectors such as biomedicine, new energy vehicles, low-altitude economy, and specialized industry testing to enhance laboratory capacity utilization and operational efficiency [2]. - With the optimization of its client structure, revenue is anticipated to gradually return to normal levels [2]. Industry Policy and Environment - The implementation of the electric passenger vehicle export license management policy starting January 2026 is expected to increase testing demand [3]. - The company is transitioning from a single testing service provider to a comprehensive role that includes quality solutions and technical consulting for automotive companies, aiding them in meeting overseas market compliance requirements [3]. Current Operating Status - Despite an expected loss of 200 to 250 million yuan for the full year of 2025, the company is striving to reduce losses through cost-cutting and management optimization [4]. - The net profit attributable to the parent company for the third quarter of 2025 has improved by 69.40% year-on-year, with future attention needed on the 2025 annual report and 2026 quarterly performance to see if the improvement trend continues [4]. Recent Stock Performance - The stock price was previously boosted by concepts like commercial aerospace, but the company announced no undisclosed significant changes [5]. - Investors are advised to be cautious of short-term volatility risks and to monitor actual order progress and capacity release [5].

北京德恒律师事务所 关于 谱尼测试集团股份有限公司 2026 年第一次临时股东会的 法律意见 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话:010-52682888 传真:010-52682999 邮编:100033 关于谱尼测试集团股份有限公司 北京德恒律师事务所 2026 年第一次临时股东会的法律意见 北京德恒律师事务所 关于 谱尼测试集团股份有限公司 致：谱尼测试集团股份有限公司 北京德恒律师事务所接受谱尼测试集团股份有限公司（以下简称"公司"）委 托，指派丘汝律师、刘元军律师（以下简称"本所律师"）出席公司 2026 年第一 次临时股东会（以下简称"本次股东会"），对本次股东会的合法性进行见证并出 具法律意见。 本法律意见根据《中华人民共和国公司法》(以下简称"《公司法》")、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以 下简称"《股东会规则》"）等现行有效的法律、法规、规范性文件以及《谱尼测 试集团股份有限公司章程》（以下简称"《公司章程》"）的规定而出具。 为出具本法律意见，本所律师审查了公司本次股东会的有关文件和材料，同时 本所律师出席本次股东 ...

证券代码：300887 证券简称：谱尼测试 公告编号：2026-009 谱尼测试集团股份有限公司 2026 年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 特别提示： 2、本次股东会未涉及变更以往股东会决议的情形。 一、会议召开情况 1、谱尼测试集团股份有限公司（以下简称"公司"）2026 年第一次临时股东会通知于 2026 年 1 月 27 日在中国证监会指定信息披露网站巨潮资讯网（http://www.cninfo.com.cn）上以 公告形式发出，本次股东会采取现场投票及网络投票相结合的方式召开。 2、会议召开时间： （1）现场会议时间：2026 年 2 月 11 日下午 15:00 （2）网络投票时间：2026 年 2 月 11 日 通过深圳证券交易所交易系统进行网络投票的时间为 2026 年 2 月 11 日 9:15-9:25， 9:30-11:30 和 13:00-15:00。 通过深圳证券交易所互联网投票系统进行网络投票的时间为 2026 年 2 月 11 日上午 9:15 至下午 15:00 期间的任意时间。 3、 ...

Group 1: Innovation in Medical Technology - Innovation Medical (002173) has established itself in the medical service sector, focusing on brain-computer interface (BCI) technology for clinical applications, particularly in neuro-rehabilitation and cardiovascular treatment [1][20] - The company's BCI-4000 product is in Phase III clinical trials, utilizing invasive electrodes to collect brain signals for device control, aiding rehabilitation for high-level paraplegics [1][20] - With the implementation of insurance reimbursement policies for BCI, the clinical transition process is expected to accelerate, potentially leading to significant growth in the neuro-rehabilitation business [1][20] Group 2: Digital Entertainment and AI Integration - Talking Tom (300459) leverages its popular IPs in digital entertainment and is actively exploring the integration of AI with brain-computer interfaces to create immersive interactive experiences [2][21] - The core business includes IP operation, mobile app development, and digital content creation, focusing on leisure and children's education [2][21] - The company aims to develop brain-controlled games and immersive entertainment applications, enhancing user engagement and monetization capabilities [2][21] Group 3: Precision Components in Medical Devices - Meihua Medical (301363) specializes in manufacturing precision medical components, providing essential support to global medical device companies, and has recently entered the brain-computer interface supply chain [3][22] - The company produces components for cardiovascular and neuro-interventional devices, including precision structural parts for BCI equipment [3][22] - As demand for BCI devices increases, the company anticipates a steady growth in orders for precision components, enhancing collaboration with BCI firms [3][22] Group 4: AI and Brain-Computer Interface Algorithms - Yanshan Technology (002195) focuses on brain-like intelligence and AI, with a strong emphasis on developing neural signal decoding algorithms for brain-computer interfaces [4][23] - The company aims to optimize brain signal decoding efficiency through AI algorithms, enhancing the precision control capabilities of BCI devices [4][23] - As the demand for algorithm precision in BCI increases, the company expects growth in algorithm licensing and system integration services [4][23] Group 5: Network Solutions for Brain-Computer Interfaces - StarNet Ruijie (002396) is a leading provider of network equipment and solutions, exploring network support solutions for brain-computer interface applications [5][25] - The company offers high-speed data transmission and processing solutions for BCI devices, facilitating real-time brain signal transmission and cloud analysis [5][25] - With the rising demand for data transmission efficiency in BCI, the company anticipates continued growth in high-speed network equipment demand [5][25] Group 6: Pain Management and Neuroregulation - Aipeng Medical (300753) specializes in pain management and neuroregulation, exploring the application of brain-computer interfaces in postoperative pain relief and neuro-rehabilitation [6][26] - The company focuses on developing devices for pain management and neuroregulation, aiming to enhance treatment efficiency through brain-computer technology [6][26] - As the demand for neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [6][26] Group 7: Security and Identity Verification - Entropy Technology (301330) leverages biometric recognition and identity verification technologies, applying brain-computer interfaces in security and identity authentication [7][27] - The company provides solutions for financial, governmental, and transportation sectors, focusing on the development of BCI applications for secure interactions [7][27] - As the demand for precision and security in identity verification increases, the potential for BCI applications in security will gradually be realized [7][27] Group 8: Smart Control Components and IoT Solutions - Yingqu Technology (002925) specializes in smart control components and IoT solutions, providing essential support for brain-computer interface devices [8][28] - The company serves consumer electronics and smart home sectors, offering smart control components that facilitate intelligent interaction and data collection for BCI devices [8][28] - With the rising demand for intelligent BCI devices, the company expects a continuous increase in orders for smart control components [8][28] Group 9: Precious Metal Materials for BCI Electrodes - Guiyan Platinum (600459) focuses on the research and production of precious metal materials, providing critical materials for brain-computer interface electrodes [9][29] - The company supplies platinum-based alloy materials that enhance the biocompatibility and signal stability of BCI electrodes [9][29] - As the demand for mass production of BCI electrodes increases, the company anticipates a steady growth in orders for precious metal materials [9][29] Group 10: Automotive Applications of Brain-Computer Interfaces - Yachuang Electronics (301099) is exploring the application of brain-computer interfaces in smart driving, focusing on automotive-grade chips and power semiconductors [10][30] - The company aims to implement brain control technology for vehicle operation, opening new possibilities in automotive intelligence [10][30] - As the demand for human-machine interaction in smart driving increases, the potential for BCI applications in the automotive sector will gradually be realized [10][30] Group 11: Industrial Applications of Brain-Computer Interfaces - Zhongke Information (300678) focuses on intelligent monitoring and industrial detection, applying brain-computer interfaces in industrial settings [11][31] - The company aims to utilize brain signals for equipment status monitoring and fault prediction, enhancing industrial efficiency [11][31] - As the demand for monitoring precision in industrial automation increases, the application of BCI in industrial settings is expected to accelerate [11][31] Group 12: Third-Party Testing for BCI Compliance - Puni Testing (300887) is a leading third-party testing organization, providing compliance testing services for brain-computer interface devices [12][32] - The company offers testing for biocompatibility and electromagnetic compatibility, ensuring the safety and compliance of BCI products [12][32] - As the BCI industry matures, the demand for compliance testing services is expected to grow, supporting the healthy development of the industry [12][32] Group 13: Flexible Materials for BCI Devices - Pulit (002324) specializes in the research and production of polymer materials, providing essential flexible packaging materials for brain-computer interface devices [13][33] - The company enhances the durability and biocompatibility of BCI devices through its flexible packaging solutions [13][33] - As the demand for flexible materials in BCI devices increases, the company anticipates a steady growth in orders for packaging materials [13][33] Group 14: Intelligent Equipment and Robotics - Tianqi Co., Ltd. (002009) focuses on intelligent equipment manufacturing and industrial automation, exploring the application of brain-computer interfaces in industrial robotics [14][34] - The company aims to implement brain control technology for precise robotic operation, enhancing manufacturing efficiency [14][34] - As the demand for precision in industrial automation increases, the application of BCI in robotics is expected to accelerate [14][34] Group 15: Medical Rehabilitation and Training - Chengyitong (300430) specializes in pharmaceutical intelligent manufacturing and rehabilitation equipment, exploring the application of brain-computer interfaces in rehabilitation training [15][35] - The company focuses on optimizing rehabilitation plans through brain control technology, enhancing training efficiency [15][35] - As the demand for neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [15][35] Group 16: Military Communication and Navigation - Haige Communication (002465) is a core enterprise in military communication and navigation, providing specialized support for brain-computer interfaces [16][36] - The company offers military communication and data transmission solutions for BCI devices, enhancing interaction in specialized scenarios [16][36] - As the demand for BCI in military applications increases, the need for communication equipment is expected to grow [16][36] Group 17: Smart Terminals and Information Systems - Nanjing Panda (600775) leverages electronic manufacturing and communication technology, exploring the application of brain-computer interfaces in smart terminals [17][37] - The company aims to implement brain control technology for device operation, opening new possibilities in consumer electronics [17][37] - As the demand for interactive methods in smart terminals increases, the potential for BCI applications in consumer electronics will gradually be realized [17][37] Group 18: Biocompatible Coatings for BCI Devices - Taihe Technology (300801) specializes in fine chemicals and water treatment materials, providing essential biocompatible coating materials for brain-computer interface devices [18][38] - The company enhances the safety and durability of BCI devices through its biocompatible coatings [18][38] - As the demand for biocompatibility in BCI devices increases, the company anticipates a steady growth in orders for coating materials [18][38] Group 19: Cardiovascular and Neurointerventional Applications - Lepu Medical (300003) focuses on cardiovascular and neurointerventional fields, exploring the application of brain-computer interfaces in cardiac rehabilitation and neuroregulation [19][39] - The company aims to optimize treatment plans through brain control technology, enhancing rehabilitation efficiency [19][39] - As the demand for cardiovascular and neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [19][39] Group 20: Intelligent Nursing and Patient Monitoring - Yahua Electronics (301337) specializes in medical information systems and intelligent nursing devices, exploring the application of brain-computer interfaces in patient monitoring [20][40] - The company aims to utilize brain signals for real-time patient status monitoring, enhancing medical service efficiency [20][40] - As the demand for precise monitoring in medical services increases, the application of BCI in healthcare settings is expected to accelerate [20][40]

Core Viewpoint - In 2025, a total of 50 batches of cosmetics were found to be non-compliant during sampling inspections conducted by the National Medical Products Administration, with brands such as Qiaoyinzi, Kangzhiben, and Weitalili involved, highlighting significant quality control issues in the cosmetics industry [1] Group 1: Non-compliance Issues - 50 batches of cosmetics were identified as non-compliant, including various product types such as conditioners, shampoos, whitening creams, and sunscreens [1] - Among the non-compliant products, 7 batches had excessive total bacterial counts, accounting for approximately 14% of the total [1] Group 2: Bacterial Count Findings - Specific products with excessive bacterial counts include Qiaoyinzi Herbal Cleansing Mud Mask with 7.5×10 CFU/g and Qiaoyinzi Ginger Refreshing Shampoo with 1,500,000 CFU/ml [3] - The total bacterial count is a critical indicator of product quality and consumer safety, with potential health risks associated with using contaminated cosmetics [3] Group 3: Regulatory Standards - The "Cosmetic Safety Technical Specifications (2015 Edition)" stipulates that the total bacterial count for eye, lip, and children's cosmetics must not exceed 500 CFU/ml (g), while other cosmetics must not exceed 1,000 CFU/ml (g) [4] - Additionally, 31 batches of cosmetics failed to meet the "ingredient comparison" requirements, particularly in sunscreen and hair dye products [4] Group 4: Causes of Non-compliance - Factors contributing to non-compliance include inadequate supply chain and raw material management, as well as quality control failures during production [4][5] - Issues such as insufficient cleaning validation during production, measurement errors, and uncontrolled process parameter changes are identified as potential risk factors [5]

Group 1 - A total of 1 listed company has its restricted shares unlocked on February 5, with a total market value of approximately 21.46 million [1] - The specific details of the restricted share unlock include the company "Puni Testing" with stock code 300887, which has 17,100 shares released from equity incentive restrictions [2]

Group 1 - The professional services sector increased by 2.79% on February 3, with Guangdian Measurement leading the gains [1] - The Shanghai Composite Index closed at 4067.74, up 1.29%, while the Shenzhen Component Index closed at 14127.1, up 2.19% [1] - Key stocks in the professional services sector showed significant price increases, with Guangdian Measurement rising by 6.33% to a closing price of 24.52 [1] Group 2 - The professional services sector experienced a net inflow of 82.0042 million yuan from institutional investors, while retail investors saw a net outflow of 38.7334 million yuan [2] - Major stocks like Huace Testing and Guangdian Measurement had notable net inflows from institutional investors, with Huace Testing receiving 56.1501 million yuan [3] - The overall trading volume and turnover for key stocks in the sector indicate strong market interest, with Huace Testing achieving a turnover of 5.87 billion yuan [1][3]

Group 1 - The article highlights various job openings in the instrumentation sector, emphasizing the demand for skilled sales engineers and technical roles across multiple companies [3][4][5][6][7][8][9][10][12][13][16][17][18][19][20][22][24][27][29][35][36] - Positions require a range of qualifications, typically a bachelor's degree or higher in relevant fields such as chemistry, biology, or engineering, with many roles preferring candidates with prior sales experience in the instrumentation or related industries [6][9][12][19][22][35] - Salary ranges for these positions vary significantly, with some roles offering monthly salaries between 8,000 to 55,000 RMB, depending on experience and specific job responsibilities [4][7][18][27][35] Group 2 - Companies are looking for candidates with strong interpersonal skills, the ability to work under pressure, and a commitment to continuous learning and professional development [6][9][12][19][22][35] - Many job descriptions emphasize the importance of technical knowledge related to laboratory instruments and the ability to provide solutions tailored to client needs [16][19][22][35] - The article indicates a trend towards remote collaboration and the use of CRM and data analysis tools in sales processes, reflecting the evolving nature of the industry [12][19][22][35]